Too strong, too late: A person's immune system eventually gets its act together and mounts a massive attack against Ebola. But in the end, the immune system overreacts and causes huge amounts of collateral damage.
The Company shall invent, develop, and provide to the laboratory, Nanoviricides® that are expected to be capable of attacking a multiplicity of different Ebola and Marburg viruses. The Laboratory shall assess in vitro and in vivo activity of the anti-Ebola Nanoviricides® provided against the virus. link: www.nanoviricides.com
A scanning electron microscopic image of HIV. The glycoprotein complex on its surface enables the virus to attach to and fuse with target cells to initiate the infectious cycle. How Nano Sized Colloidal Silver Kills Bacteria:)